This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit US


  • 00
  • 00
  • 00
  • 00
December 6 - 8, 2022
Intercontinental Chicago Magnificent MileChicago, IL

Nicole Soucy, Ph.D., DABT
Director, Global Toxicology and Biocompatibility at Boston Scientific


Nicole Soucy received a PhD in pharmacology and toxicology from Dartmouth College in 2003, where her research investigated mechanisms for cardiovascular disease following exposure to metals and metalloids. This was followed by a post-doctoral fellowship at the Chemical Industry Institute of Toxicology (CIIT) where her research focus was on gestational pharmacokinetics of endocrine disrupting compounds. Nicole has worked in the medical device industry since 2006 where she has designed and managed preclinical safety programs to support IDE/PMA submissions for stent and balloon based drug delivery programs, led technology development projects to support the biological evaluation of combination medical device products, and has led teams of toxicologists and biocompatibility specialists for two major medical device manufacturers, including businesses with contract pharmaceutical R&D and manufacturing operations. A Diplomate of the American Board of Toxicology (DABT) since 2012, Nicole currently serves as President of the ABT Board of Directors.

Agenda Sessions

  • Multi-Stakeholder Panel: Interaction of EU MDR and Biocompatibility

  • Global ‘de-harmonization’ of Biocompatibility Expectations”

  • Panel: Assessing The Future of In Vitro Testing